Shares of Cupid Ltd soared as much as 10% during Thursday’s session to ₹146.04, extending its sharp rally this year. The stock, which is already up over 100% in 2025 so far, has gained nearly 20% in just the past week, supported by heavy volumes and strong investor sentiment.
At around 10:10 AM, the stock was trading at ₹146, up 9.26% from its previous close of ₹133.66 on the NSE. The stock also touched a new 52-week high of ₹147 in early trade.
What’s driving the rally?
Recently, Cupid Limited announced its first strategic investment in the Middle East healthcare sector, marking a milestone in its global expansion plans. The company invested in GII Healthcare Investment Limited, managed by Gulf Islamic Investments (GII), which oversees over $3.5 billion in assets and has a presence across Saudi Arabia, UAE, Europe, USA, and India.
This healthcare investment vehicle holds a significant minority stake in a leading Saudi Arabian healthcare provider. Through this move, Cupid aims to tap into high-growth healthcare and wellness markets globally, aligning with its strategy of promoting preventive healthcare and expanding internationally.
Cupid manufactures a wide range of health and personal care products, including hygiene items, diagnostic kits, fragrances, and other FMCG products. Management reiterated that this investment aligns with its long-term business strategy while remaining committed to shareholders’ interests and responsible growth.
Stock performance
-
Today: +9.26% at ₹146.04
-
1 Week: ~+20%
-
6 Months: ~+103%
-
Year-to-date (2025): more than doubled
Investors appear upbeat on the company’s prospects in new markets and its focus on healthcare, which has been reflected in the strong price action over recent months.
